What Are the Fundamentals of Thermo Fisher Scientific (TMO)?

Shares of Large-cap industrials company Thermo Fisher Scientific moved -6.2 this afternoon, and are now trading at $429.97 per share. On the other hand, the average analyst target price for the stock is $601.88.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.

Thermo Fisher Scientific Investors Should Consider This:

  • Thermo Fisher Scientific has moved -14.0% over the last year.

  • The company has a price to earnings growth (PEG) ratio of 3.7. A number between 0 and 1 could mean that the market is undervaluing Thermo Fisher Scientific's estimated growth potential

  • Its Price to Book (P/B) ratio is 3.79

  • Thermo Fisher Scientific currently returns an annual dividend yield of 0.3%.

Understanding Thermo Fisher Scientific's Operating Margins

Date Reported Total Revenue ($ k) Operating Expenses ($ k) Operating Margins (%) YoY Growth (%)
2023 43,524,000 36,812,000 15 -21.05
2022 44,915,000 36,522,000 19 -26.92
2021 39,211,000 29,183,000 26 8.33
2020 32,218,000 24,424,000 24 33.33
2019 25,542,000 20,948,000 18 12.5
2018 24,358,000 20,575,000 16

Over the last 6 years, Thermo Fisher Scientific's operating margins have averaged 19.7%, which is better than the 13.8% Farm & Heavy Construction Machinery industry average. We also note that the company's operating margins have a high coefficient of variability at 127.0%. The firm's margins exhibit a relatively stable growth trend of -0.6%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.